冠状动脉钙化与慢性肾脏病患者不良心血管结局及死亡的关联:KNOW-CKD研究结果
在韩国慢性肾脏病(CKD)G1-G5期未接受肾脏替代治疗的1579例患者中,中位随访5.1年,冠状动脉钙化积分(CACS)每增加1个标准差(对数)与主要结局风险升高1.67倍独立相关;CACS>400者主要结局风险为CACS=0者的4.89倍,且CACS对主要结局预测的改善幅度有限。
要点
- CACS每增加1个标准差(对数),主要结局风险升高1.67倍(95%CI 1.37-2.04)。
- CACS>400者主要结局风险为CACS=0者的4.89倍(95%CI 2.68-8.93)。
- CACS对主要结局预测的改善幅度有限,但优于传统心血管危险因素。
核心结论
- 在韩国CKD患者中,CACS与不良心血管结局及全因死亡独立相关。
- CACS对主要结局的预测性能较传统心血管危险因素有适度改善。
研究设计与样本
- 韩国CKD结局队列研究(KNOW-CKD)为多中心、前瞻性观察性研究。
- 纳入2011年至2016年间1579例CKD G1-G5期未接受肾脏替代治疗的参与者。
- 主要预测因素为冠状动脉钙化积分(CACS)。
- 主要结局为非致死性心血管事件或全因死亡的复合终点。
- 次要结局包括3点主要不良心血管事件(MACE;心血管死亡、非致死性心肌梗死或非致死性卒中的复合终点)、所有心血管事件及全因死亡。
主要发现
- 中位随访5.1年期间,共发生123例主要结局事件(发生率1.6/100人年)。
- 多变量Cox模型中,CACS对数每增加1个标准差,主要结局风险升高1.67倍(95%CI 1.37-2.04)。
- 与CACS=0相比,CACS>400者主要结局的风险比为4.89(95%CI 2.68-8.93)。
- 该关联在次要结局中保持一致。
- 与已知传统危险因素相比,纳入CACS使主要结局的预测指标有适度改善。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In East Asian countries, patients with chronic kidney disease (CKD) have lower cardiovascular risk profiles and experience fewer cardiovascular events (CVEs) than those in Western countries. Thus the clinical predictive performance of well-known risk factors warrants further testing in this population. METHODS: The KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD) is a multicenter, prospective observational study. We included 1579 participants with CKD G1-G5 without kidney replacement therapy between 2011 and 2016. The main predictor was the coronary artery calcium score (CACS). The primary outcome was a composite of nonfatal CVEs or all-cause mortality. Secondary outcomes included 3-point major adverse cardiovascular events (MACEs; the composite of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke), all CVEs and all-cause mortality. RESULTS: During a median follow-up of 5.1 years, a total of 123 primary outcome events occurred (incidence rate 1.6/100 person-years). In the multivariable Cox model, a 1-standard deviation log increase in the CACS was associated with a 1.67-fold [95% confidence interval (CI), 1.37-2.04] higher risk of the primary outcome. Compared with a CACS of 0, the hazard ratio associated with a CACS >400 was 4.89 (95% CI 2.68-8.93) for the primary outcome. This association was consistent for secondary outcomes. Moreover, inclusion of the CACS led to modest improvements in prediction indices of the primary outcome compared with well-known conventional risk factors. CONCLUSIONS: In Korean patients with CKD, the CACS was independently associated with adverse cardiovascular outcomes and all-cause death. The CACS also showed modest improvements in prediction performance over conventional cardiovascular risk factors.
引用
- Jung CY, Yun HR, Park JT, et al. Association of coronary artery calcium with adverse cardiovascular outcomes and death in patients with chronic kidney disease: results from the KNOW-CKD. Nephrol Dial Transplant. 2023. PMID: 35689669. doi:10.1093/ndt/gfac194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。